Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
ClinicalTrials.gov study NCT01516580. IPD Sharing: Not stated. Countries: 10. Publications: 3.
B Cell Functions in Periodontitis
ClinicalTrials.gov study NCT02833285. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology
ClinicalTrials.gov study NCT06378190. IPD Sharing: YES. Countries: 1. Publications: 1.
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT05583149. IPD Sharing: YES. Countries: 1. Publications: 0.
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT03233854. IPD Sharing: NO. Countries: 1. Publications: 3.
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
ClinicalTrials.gov study NCT04542824. IPD Sharing: NO. Countries: 1. Publications: 1.
CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies
ClinicalTrials.gov study NCT04605666. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00169143. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma
ClinicalTrials.gov study NCT01582776. IPD Sharing: NO. Countries: 2. Publications: 3.
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemo
ClinicalTrials.gov study NCT02354846. IPD Sharing: Not stated. Countries: 1. Publications: 1.
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
ClinicalTrials.gov study NCT03424122. IPD Sharing: NO. Countries: 3. Publications: 0.
An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
ClinicalTrials.gov study NCT01340443. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01846390. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
ClinicalTrials.gov study NCT04836507. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
ClinicalTrials.gov study NCT02012088. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT01351935. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms
ClinicalTrials.gov study NCT01704963. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab
ClinicalTrials.gov study NCT00349349. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
ClinicalTrials.gov study NCT03939026. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT03223610. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.